CATALYST PHARMACEUTICALS INC

Ticker: CPRX CUSIP: 14888U101 Class: Common Stock

Yorktown Management & Research Co Inc's Holding History (CIK: 0001313559)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 17,300 Value ($000) $341 Avg Close $20.57 Range $19.05 - $22.53
Q2 2025
Shares 17,300 Value ($000) $375 Avg Close $23.61 Range $20.40 - $26.58
Q1 2025
Shares 37,550 Value ($000) $911 Avg Close $22.52 Range $19.15 - $26.16
Q4 2024
Shares 37,550 Value ($000) $784 Avg Close $21.48 Range $19.54 - $24.27
Q3 2024
Shares 37,550 Value ($000) $746 Avg Close $18.54 Range $14.97 - $21.67
Q2 2024
Shares 20,250 Value ($000) $314 Avg Close $15.57 Range $14.47 - $17.03
Q1 2024
Shares 40,500 Value ($000) $646 Avg Close $15.07 Range $13.12 - $17.50
Q4 2023
Shares 40,500 Value ($000) $681 Avg Close $13.67 Range $11.55 - $17.40
Q3 2023
Shares 40,500 Value ($000) $473 Avg Close $13.38 Range $11.59 - $15.59
Q2 2023
Shares 40,500 Value ($000) $544 Avg Close $14.39 Range $11.09 - $18.22
Q1 2023
Shares 50,000 Value ($000) $829 Avg Close $16.50 Range $13.30 - $22.11
Q4 2022
Shares 50,000 Value ($000) $930 Avg Close $15.40 Range $12.08 - $19.78
Q3 2022
Shares 50,000 Value ($000) $642 Avg Close $11.85 Range $6.87 - $17.22
Q2 2022
Shares 50,000 Value ($000) $351 Avg Close $7.33 Range $6.15 - $8.65